Login/Sign Up
Merycet 30 Tablet
₹895.5*
MRP ₹995
10% off
₹846*
MRP ₹995
15% CB
₹149 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Merycet 30 Tablet is used to treat primary hyperparathyroidism, secondary hyperparathyroidism, and parathyroid-carcinoma. Primary hyperparathyroidism is a condition in which one or more parathyroid glands make too much parathyroid hormone (PTH). Secondary hyperparathyroidism is the medical condition of excessive secretion of parathyroid hormone (PTH) by the parathyroid glands in response to hypocalcemia (low blood calcium levels), with resultant hyperplasia (increase in the number of cells) of these glands. Parathyroid cancer is a rare disease in which malignant (cancer) cells form in a parathyroid gland's tissues.
Merycet 30 Tablet contains 'cinacalcet', which works by signalling the body to produce a less parathyroid hormone to decrease the amount of calcium in the blood.
In some cases, Merycet 30 Tablet may cause common side effects like vomiting, nausea, rash, headache, muscle pain, and diarrhoea. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, consult a doctor.
Do not take Merycet 30 Tablet if you are allergic to ‘cinacalcet’ or other ingredients. Inform your doctor if you are taking any other medicines other than Merycet 30 Tablet. Before taking Merycet 30 Tablet, inform your doctor if you have chronic kidney disease, gastrointestinal bleeding, heart failure, liver diseases, or cardiac arrhythmia. Merycet 30 Tablet is not recommended in hypotension and hypocalcemia. Consult your doctor if you are pregnant or breastfeeding.
Merycet 30 Tablet contains 'cinacalcet', which belongs to the class of medications called 'calcimimetics' used in the treatment of primary hyperparathyroidism, secondary hyperparathyroidism, and parathyroid-carcinoma. It works by signalling the body to produce a less parathyroid hormone to decrease the amount of calcium in the blood.
Fever or chills
Vomiting
Nausea
Rash
Blurred vision
Chest pain
Headache
Lower back or side pain
Nervousness
Difficult or painful urination
Diarrhoea
Do not take Merycet 30 Tablet if you are allergic to any of its ingredients. Inform your doctor if you are taking medicines other than Merycet 30 Tablet. Before taking Merycet 30 Tablet, inform your doctor if you have chronic kidney disease, gastrointestinal bleeding, heart failure, liver diseases, adynamic bone disease, or cardiac arrhythmia. Consult your doctor if you are pregnant or breastfeeding. Before taking Merycet 30 Tablet, inform your doctor if you have rare hereditary problems of galactose intolerance.
Drug-Drug Interactions: Merycet 30 Tablet may interact with antifungal drugs (ketoconazole and itraconazole), antacids (Balofloxacin), anti-depressant (amitryptiline, amoxapine, pimozide, thioridazine, fluvoxamine, imipramine), a protease inhibitor (indinavir, ritonavir), antibiotics (clarithromycin, erythromycin), hormonal drugs (tamoxifen), antiarrhythmics (flecainide, carvedilol, verapamil), anti-cancer (vinblastine), anti-TB (rifampicin).
Drug-Food Interactions: Do not take grapefruit or grapefruit juice while using Merycet 30 Tablet.
Drug-Disease Interactions: Merycet 30 Tablet should be used with caution in patients with chronic kidney disease, gastrointestinal bleeding, heart failure, liver diseases, adynamic bone disease, cardiac arrhythmia, hypotension, hypocalcemia, or galactose intolerance.
Avoid refined foods, such as white bread, pasta, and sugar.
Use healthy cooking oils, such as olive oil or coconut oil.
Drink plenty of fluids.
Exercise regularly.
Don't smoke.
Monitor your calcium levels regularly during treatment with Merycet 30 Tablet. Inform your doctor if you notice signs of low calcium levels, such as numbness or tingling around the mouth or muscle aches.
Hyperparathyroidism: Hyperparathyroidism is a condition in which one or more of your parathyroid glands become overactive and release (secrete) too much parathyroid hormone (PTH). This causes the levels of calcium in your blood to rise, a condition known as hypercalcemia. There are two types of hyperparathyroidism: primary and secondary.
Primary hyperparathyroidism: Primary hyperparathyroidism is a condition in which one or more parathyroid glands make too much parathyroid hormone (PTH). This can lead to the loss of bone tissue. Symptoms include constipation, frequent urination, increased thirst, joint pain, kidney pain (due to kidney stones), loss of appetite, and muscle weakness.
Secondary hyperparathyroidism: Secondary hyperparathyroidism is the medical condition of excessive secretion of parathyroid hormone (PTH) by the parathyroid glands in response to hypocalcemia (low blood calcium levels), with resultant hyperplasia (increase in the number of cells) of these glands. This disorder is primarily seen in patients with chronic kidney failure. Symptoms include muscle pain and weakness.
Parathyroid cancer: Parathyroid cancer is a rare disease in which malignant (cancer) cells form in a parathyroid gland's tissues. Symptoms include weakness, tiredness, nausea, vomiting, loss of appetite, weight loss for no known reason, being much more thirsty than usual, urinating much more than usual, and constipation.
Alcohol
Caution
Merycet 30 Tablet with alcohol may cause unpleasant effects. So please consult your doctor before taking Merycet 30 Tablet with alcohol.
Pregnancy
Caution
Merycet 30 Tablet is not recommended for use in pregnant women unless necessary. Before taking this medicine, the risks and benefits should be discussed with the doctor.
Breast Feeding
Caution
Merycet 30 Tablet is not recommended for use in breastfeeding women unless necessary. Before taking this medicine, the risks and benefits should be discussed with the doctor. Your doctor may advise you to discontinue the medicine or breastfeeding based on your clinical condition.
Driving
Caution
Merycet 30 Tablet may cause blurred vision, dizziness, and drowsiness in some patients. You are advised not to perform any activities, such as driving a vehicle or operating machinery, if you experience any of these symptoms during treatment with this medicine.
Liver
Caution
Merycet 30 Tablet should be used with caution in patients with liver disease. A dose adjustment of Merycet 30 Tablet may be needed in some cases. So, Please consult your doctor.
Kidney
Caution
Merycet 30 Tablet is not recommended for use in patients suffering from chronic kidney disease who are not being treated with dialysis due to the increased risk of hypocalcemia (low blood calcium levels). Depending on your clinical condition, dose adjustments or replacement with a suitable alternative drug should be considered.
Children
Caution
Merycet 30 Tablet should not be used in children below 12 years of age unless prescribed by a doctor.
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes